neostem inc (NBS:NASDAQ CM)
Andrew L. Pecora M.D., F.A.C.P.
Chief Visionary Officer, Director, Chief Scientific Officer of Amorcyte Inc and Chief Medical Officer of Progenitor Cell Therapy Llc , Neostem, Inc.
|Age||Total Calculated Compensation||This person is connected to 54 board members in 4 different organizations across 7 different industries.|
See Board Relationships
As of Fiscal Year 2013
Dr. Andrew L. Pecora, M.D., F.A.C.P., has been the Chief Visionary Officer of Neostem, Inc., since August 5, 2013. Dr. Pecora founded Amorcyte, LLC in 2005 and serves as its Chief Scientific Officer. He is the Founder and Executive Chairman of Cota. He serves as the Chairman of Cancer Center Department at Hackensack University Medical Center. He served as the Chief Medical Officer of Progenitor Cell Therapy, LLC , a wholly-owned Subsidiary of Neostem, Inc. since January ...
420 Lexington AvenuePhone: 212-584-4180
New York, New York 10170
Board Members Memberships*
Former Chairman of the Board, Chief Executive Officer, Chief Medical Officer and Member of Board Manager
Founder and Chief Scientific Officer
Founder and Executive Chairman
Chief Visionary Officer, Director, Chief Scientific Officer of Amorcyte Inc and Chief Medical Officer of Progenitor Cell Therapy Llc
University of Medicine and Dentistry of New Jersey
Seton Hall University
|Gil Van Bokkelen Ph.D.||Co-Founder, Chairman and Chief Executive Officer|
|Michael D. West Ph.D.||Chief Executive Officer, President and Director|
|Marc H. Hedrick M.D.||Chief Executive Officer, President, Director and Member of Executive Committee|
Cytori Therapeutics, Inc.
|Paul K. Wotton Ph.D.||Chief Executive Officer, President, Director and Member of Pricing Committee|
Advanced Cell Technology Inc.
|Zami Aberman||Executive Chairman and Chief Executive Officer|
Pluristem Therapeutics, Inc.
|$503.7K||Compensation as of Fiscal Year 2013.|